32 results
ARS
2024 FY
CCCC
C4 Therapeutics Inc
30 Apr 24
Annual report to shareholders
8:52am
, quality control, safety, effectiveness, labeling, storage, packaging, recordkeeping, tracking, approval, import, export, distribution, advertising … packaging must be selected and tested, and stability studies must be conducted to demonstrate that the product candidate does not undergo unacceptable
8-K
EX-10.1
mmg0 pc5o
30 May 23
Entry into a Material Definitive Agreement
7:30am
ARS
54i000p3g8gy
28 Apr 23
Annual report to shareholders
7:03am
424B4
kjnug 9jmtx
21 Jun 21
Prospectus supplement with pricing info
8:08am
DRS
a74uf4w
19 May 21
Draft registration statement
12:00am